Back to News
Market Impact: 0.2
Veridian Healthcare Completes Acquisition of ScarScience Brand from Mitchell-Vance Laboratories
Source: PR Newswire
M&A & RestructuringHealthcare & BiotechPrivate Markets & Venture
Veridian Healthcare, a portfolio company of HealthEdge Investment Partners and United Western Group, completed the acquisition of the ScarScience brand and related assets from Mitchell-Vance. The transaction expands Veridian's healthcare brand portfolio, though no purchase price, financial terms, or expected earnings impact were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
More News
- Blackstone Sees India Nearing Tipping Point for Foreign Capital
- Japan has record 100,000 people aged over 100: How societies are ageing
- Flock Offers Employees Buyouts as Customers Flee
- Anthropic’s Claude Takes Bigger Role in Building AI
- Synaptics SVP Lisa Bodensteiner sells $30,938 in stock
- Volkswagen and Porsche Holding cut outlook
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Can ChatGPT or Claude Replace a Research Platform?
- How the 2026 Milan-Cortina Winter Olympics Will Reshape Company Revenues and Stock Performance